Publication | Closed Access

Homoharringtonine in combination with cytarabine and aclarubicin in the treatment of refractory/relapsed acute myeloid leukemia: a single-center experience

Hematological MalignancyMedicinal ChemistryMedicineMixed-phenotype Acute LeukemiaHematologyPharmacologySingle-center ExperiencePharmacotherapyOncologyMyeloid Neoplasia